Literature DB >> 6432419

The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis.

A Larsen, J Horton, C Howland.   

Abstract

X-rays from patients in comparative studies of auranofin and parenteral gold were obtained before and during treatment, and analysed using a modification of the method of Larsen. One hundred and nineteen auranofin-treated and 113 parenteral gold-treated patients contributed data, which were analysed for changes from 0-6 months, 0-12 months and from 0-6 and 12 months. Progression of erosive processes and of joint grade occurred with both treatments, but the proportion of patients with progression in the first six months was greater with auranofin treatment. However, there was evidence that both treatments produced slowing of the erosive process during the second six months of treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432419     DOI: 10.1007/bf03342627

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  A COMPARISON of prednisolone with aspirin on other analgesics in the treatment of rheumatold rthritis.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-09       Impact factor: 19.103

2.  EMPIRE Rheumatism Council: multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis; results of three years' treatment.

Authors: 
Journal:  Ann Rheum Dis       Date:  1957-09       Impact factor: 19.103

3.  Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial.

Authors: 
Journal:  Ann Rheum Dis       Date:  1961-12       Impact factor: 19.103

4.  Gold therapy in early rheumatoid arthritis.

Authors:  C H ADAMS; R L CECIL
Journal:  Ann Intern Med       Date:  1950-07       Impact factor: 25.391

5.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

6.  Evidence that D-penicillamine alters the course of rheumatoid arthritis.

Authors:  T Gibson; E C Huskisson; J A Wojtulewski; P J Scott; H W Balme; H C Burry; R Grahame; F D Hart
Journal:  Rheumatol Rehabil       Date:  1976-08

Review 7.  Does drug therapy slow radiographic deterioration in rheumatoid arthritis?

Authors:  L Iannuzzi; N Dawson; N Zein; I Kushner
Journal:  N Engl J Med       Date:  1983-10-27       Impact factor: 91.245

8.  Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy.

Authors:  R Luukkainen
Journal:  Scand J Rheumatol Suppl       Date:  1980

9.  Radiographic evaluation of erosion in rheumatoid arthritis: double blind study of auranofin vs placebo.

Authors:  J P Gofton; W M O'Brien; J N Hurley; B J Scheffler
Journal:  J Rheumatol       Date:  1984-12       Impact factor: 4.666

10.  Gold salts in the treatment of rheumatoid arthritis. A double-blind study.

Authors:  J W Sigler; G B Bluhm; H Duncan; J T Sharp; D C Ensign; W R McCrum
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

View more
  7 in total

1.  Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate.

Authors:  O Sander; G Herborn; E Bock; R Rau
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

Review 2.  Worldwide clinical experience with auranofin.

Authors:  R W Morris; D S Cole; J Horton; M A Heuer; R G Pietrusko
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

3.  A three year comparative study of auranofin and gold sodium thiomalate in rheumatoid arthritis.

Authors:  R Rau; M Schattenkirchner; H Muller-Fassbender; B Kaik; H Zeidler; B Missler
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

Review 4.  Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents.

Authors:  Rolf Rau
Journal:  Clin Rheumatol       Date:  2004-07-24       Impact factor: 2.980

5.  Precision of Larsen grading of radiographs in assessing progression of rheumatoid arthritis in individual patients.

Authors:  M M O'Sullivan; P A Lewis; R G Newcombe; N J Broderick; D A Robinson; E C Coles; J D Jessop
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

Review 6.  Disease-modifying antirheumatic drugs. Potential effects in older patients.

Authors:  G Gardner; D E Furst
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

7.  Contribution of patient related differences to multidrug resistance in rheumatoid arthritis.

Authors:  C Morgan; M Lunt; H Brightwell; P Bradburn; W Fallow; M Lay; A Silman; I N Bruce
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.